One-product, Two-brand Marketing Comes under Fire at CSIMC; Japanese Like Competition between Partners

Following fixed-dose combination drugs, marketing of a single product under two brand names has come under fire. At a general assembly of the Central Social Insurance Medical Council (CSIMC) on August 22, Hirotsugu Miura (vice president, Japan Pharmaceutical Association (JPA))...read more